Pharmacology

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
RCT Anesthesiology Published 10 Nov 2026
Quality of Recovery After Primary Breast Cancer Surgery: A Randomized, Two-Centre, Triple-Blinded Trial Comparing Erector Spinae Plane Block and Intravenous Lidocaine Infusion Within a Multimodal Analgesia Framework.
AI-generated abstract summary · verify against the original paper
  • Randomized, triple-blinded, placebo-controlled two-centre trial of 80 adults undergoing primary breast cancer surgery, with or without axillary dissection.
  • Patients received either an ultrasound-guided erector spinae plane block (n=40) or intraoperative IV lidocaine infusion (n=40), both within a standardized multimodal analgesic protocol.
  • The 24-hour QoR15 score was 137.7 (SD 17.9) with ESPB versus 136.3 (SD 8.8) with IVLI, p=0.61.
  • Pain scores, opioid use and rescue analgesia were similarly low in both groups, and the authors suggest IVLI may be a pragmatic option when regional expertise is limited.
PubMed indexed 10 Nov 2026 Imported 11 Nov 2026 Sivakumar RK et al. Publisher PharmacologyRegional
RCT Br J Anaesth Published 29 Oct 2026
Effect of remimazolam versus propofol anaesthesia on postoperative delirium in neurovascular surgery: a randomised noninferiority trial.
AI-generated abstract summary · verify against the original paper
  • Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
  • Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
  • Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
  • Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Kim J et al. Publisher NeuroPharmacology
RCT Drug Des Devel Ther Published 27 Oct 2026
Effect of Preoperative Intranasal Dexmedetomidine on Postoperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
  • Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
  • At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
  • Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
PubMed indexed 1 Nov 2026 Imported 9 Nov 2026 Li Q et al. Publisher CardiacPerioperative medicinePharmacology
RCT Pain Med Published 19 Oct 2026
Perineural or intravenous dexamethasone for adductor canal and iPACK blocks in total knee arthroplasty: A randomised trial.
AI-generated abstract summary · verify against the original paper
  • Randomised, quadruple-blind trial of 90 patients aged 65-100 undergoing primary total knee arthroplasty, comparing dexamethasone adjuncts to adductor canal and iPACK blocks.
  • Perineural dexamethasone (4 mg total, 2 mg per block) with ropivacaine was compared with intravenous dexamethasone 4 mg and with placebo.
  • Median time to first rescue opioid was 4.5 h with placebo, 13.9 h with IV dexamethasone and 18.5 h with perineural dexamethasone (log-rank p < 0.001).
  • Perineural dexamethasone produced lower opioid use than IV at later timepoints, and no motor weakness or nerve injury was reported.
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Reysner T et al. Publisher Chronic painPharmacologyRegional
RCT Reg Anesth Pain Med Published 5 Oct 2026
Impact of opioid-free general anesthesia with locoregional blocks during breast cancer surgery on systemic inflammatory response: results from a randomized controlled trial.
AI-generated abstract summary · verify against the original paper
  • Randomized controlled trial of 68 breast cancer patients (34 per arm) undergoing quadrantectomy, comparing opioid-free general anesthesia with locoregional blocks against opioid-based general anesthesia.
  • The primary endpoint was the neutrophil-to-lymphocyte ratio (NLR), measured before surgery and at 1 and 24 hours after; secondary endpoints included side effects, pain management, and inflammatory cytokines.
  • In the opioid-based arm, NLR rose from baseline at 1 hour (median change +0.13, IQR 0.01 to 0.62, p<0.0001) and 24 hours (+0.64, IQR 0.28 to 1.03, p<0.0001), while the opioid-free arm showed no significant change.
  • The authors conclude that opioid-free anesthesia was associated with a reduced postoperative inflammatory response without compromising pain control, and it was better tolerated with fewer side effects.
PubMed indexed 25 Jun 2025 Imported 9 Nov 2026 Brescia F et al. Publisher PharmacologyRegional
RCT Paediatr Anaesth Published 3 Oct 2026
Comparison of Methylprednisolone and Dexamethasone in Their Interaction With Sugammadex in Pediatric Patients: A Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized controlled trial of 60 children undergoing adenotonsillar surgery, allocated to methylprednisolone, dexamethasone, or no corticosteroid.
  • Children received methylprednisolone 1 mg/kg, dexamethasone 0.2 mg/kg, or no steroid before sugammadex reversal of rocuronium block.
  • Reversal time was longer with methylprednisolone (82.8 ± 16.1 s) than with dexamethasone (63.4 ± 13.4 s) or control (56.1 ± 13.7 s), p < 0.001.
  • Extubation time followed a similar pattern, while postoperative pain, nausea, and adverse event rates did not differ significantly between groups.
PubMed indexed 3 Oct 2026 Imported 9 Nov 2026 Büyükcavlak M et al. Publisher PediatricPerioperative medicinePharmacology
RCT Drug Des Devel Ther Published 2 Oct 2026
Intraoperative Dexmedetomidine and Postoperative Delirium After Head and Neck Cancer Surgery with Free-Flap Reconstruction: A Secondary Analysis of a Randomized Placebo-Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • This delirium-focused secondary analysis of a single-centre, double-blind, placebo-controlled trial enrolled adults having head and neck cancer surgery with free-flap reconstruction.
  • Patients received intraoperative dexmedetomidine at 0.3 μg/kg/h until 1 hour before surgery ended, or comparable volumes of saline placebo.
  • Delirium over the first 5 postoperative days occurred in 14.9% (7/47) of dexmedetomidine patients versus 34.7% (17/49) of placebo patients (adjusted OR 0.31, 95% CI 0.10-0.92; p = 0.036).
  • Pain and early sleep were reported as improved with dexmedetomidine, and haemodynamic adverse events and postoperative complications did not differ significantly between groups.
PubMed indexed 7 Oct 2026 Imported 9 Nov 2026 Zhang SJ et al. Publisher NeuroPerioperative medicinePharmacology
RCT JAMA Published 22 Sep 2026
Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Pragmatic, open-label, multicenter randomized trial of 2508 adults aged 50 or older having elective major noncardiac surgery at 49 UK NHS hospitals.
  • Patients were randomized 1:1 to maintenance of general anesthesia with propofol TIVA or volatile inhalational agents, with other perioperative care left to clinician discretion.
  • Days alive and at home at 30 days were similar (22.5 vs 22.4 days; incidence rate ratio 1.00, 95% CI 0.99-1.02; adjusted P = .68).
  • TIVA was associated with lower reported thirst, hoarseness, and nausea/vomiting; major complications (12.4% overall) did not differ between groups.
PubMed indexed 12 Aug 2026 Imported 9 Nov 2026 Jhanji S et al. Publisher NeuroPerioperative medicinePharmacology
RCT Drug Des Devel Ther Published 13 Sep 2026
Effects of Intranasal Dexmedetomidine on the Night Before Surgery on Postoperative Delirium in Elderly Patients Undergoing Total Knee/Hip Arthroplasty. A Parallel-Arm, Randomized Controlled, Non-Inferiority Trial.
AI-generated abstract summary · verify against the original paper
  • Single-center randomized non-inferiority trial in China with 316 randomized elderly patients (of 535 screened) undergoing elective unilateral total knee or hip arthroplasty.
  • Intranasal dexmedetomidine the night before surgery plus IV saline at induction was compared with intranasal saline plus IV dexmedetomidine before induction.
  • Delirium within 3 days by CAM occurred in 9.5% vs 7.6%; rate difference 0.02 (95% CI -0.04 to 0.08), reported P<0.001, meeting non-inferiority.
  • Authors also reported better sleep the night before surgery, lower preoperative anxiety and pain scores, and fewer adverse events with the intranasal route.
PubMed indexed 18 Sep 2026 Imported 9 Nov 2026 Chen Y et al. Publisher NeuroPharmacology
RCT Anesth Analg Published 10 Sep 2026
A Double-Blinded Randomized Trial Comparing Dexamethasone to Ondansetron as the First-Line Antiemetic After Cesarean Delivery.
AI-generated abstract summary · verify against the original paper
  • Double-blinded randomized trial of 100 women after cesarean delivery (95 completed), comparing dexamethasone 8 mg with ondansetron 4 mg.
  • Both groups received spinal anesthesia with morphine 150 µg and an enhanced recovery protocol with scheduled nonopioid analgesics; the main outcome was rescue medications for nausea, vomiting, pain, or pruritus over 24 hours.
  • Medication use did not differ significantly: ondansetron 0.23 (95% CI 0.11-0.35) versus dexamethasone 0.40 (0.20-0.61) per patient per 24 hours; P = .337.
  • Supplemental pain medication, pain scores, nausea, and pruritus scores also showed no significant differences. The authors suggest low pain scores and breakthrough pain rates may explain the lack of pain benefit seen in prior dexamethasone studies.
PubMed indexed 10 Sep 2026 Imported 9 Nov 2026 Berger AA et al. Publisher ObstetricPharmacology
RCT Crit Care Med Published 7 Sep 2026
Ketamine for Analgosedation in Mechanically Ventilated Adults: A Double-Blind Randomized Trial.
AI-generated abstract summary · verify against the original paper
  • Double-blind randomized placebo-controlled trial in 120 mechanically ventilated adults on opioid infusion at two Melbourne ICUs, excluding cardiac surgical patients.
  • Patients received low-dose ketamine infusion (0.15 mg/kg/hr) or placebo during mechanical ventilation.
  • Median hourly opioid dose was 64 µg/hr with ketamine versus 77 µg/hr with placebo (median difference -13.0, 95% credible interval -26.6 to 2.4; probability of benefit 95.1%).
  • Authors concluded low-dose ketamine appeared safe and reduced opioid requirements, while noting that delirium and most other secondary outcomes did not differ and larger trials are needed.
PubMed indexed 7 Sep 2026 Imported 9 Nov 2026 Casamento AJ et al. Publisher Critical carePharmacology
RCT Reg Anesth Pain Med Published 4 Sep 2026
Single-injection adductor canal block with perineural dexamethasone versus continuous adductor canal catheter for total knee arthroplasty: a randomized controlled trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, participant- and assessor-blinded trial of 94 patients undergoing primary unilateral total knee arthroplasty.
  • Compared a single-injection adductor canal block with perineural dexamethasone against the same block followed by a continuous adductor canal catheter infusing 0.2% ropivacaine for 50 hours.
  • No significant difference in opioid use at 24-48 hours (median 30 mg vs 38.8 mg; 95% CI -22.50 to 7.00 mg; p=0.213), and PACU opioid use was also not significantly different (p=0.081).
  • Catheter-associated buckling occurred in 7% of the continuous group versus 0% of the single-injection group, all transient; the authors concluded the catheter did not reduce opioid use.
PubMed indexed 4 Jun 2026 Imported 9 Nov 2026 Kim DH et al. Publisher PharmacologyRegional
RCT Paediatr Anaesth Published 2 Sep 2026
Up-and-Down Sequential Allocation Study Comparing the Median Effective Dose of Remimazolam Versus Propofol for Inducing Unconsciousness in Pediatric Patients.
AI-generated abstract summary · verify against the original paper
  • Randomized dose-finding trial using a Dixon up-and-down design in 50 children aged 2 to 14 years having elective surgery.
  • Children received a single intravenous bolus of remimazolam or propofol for induction, in two parallel dose-finding arms.
  • Remimazolam's ED50 for loss of consciousness was 0.17 mg/kg (95% CI 0.16-0.19) and its ED95 was 0.26 mg/kg (95% CI 0.23-0.29).
  • Heart rate was more stable with remimazolam, and no respiratory depression or hypotension occurred in either group.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Gu YL et al. Publisher PediatricPharmacology
RCT Pain Med Published 1 Sep 2026
The safety and effectiveness of lumbar transforaminal injection of sterile amniotic fluid filtrate compared to steroid for lumbosacral radicular pain due to spinal stenosis: a phase I/II double-blinded randomized trial.
AI-generated abstract summary · verify against the original paper
  • Double-blinded randomized phase I/II trial of 58 participants with radicular pain from lumbosacral spinal stenosis.
  • Transforaminal injection of sterile amniotic fluid filtrate was compared with dexamethasone, with safety and pain and function outcomes followed to 6 months.
  • At 3 months, more dexamethasone patients had at least 50% pain reduction: back 45.8% vs 15.0% (P=.050) and leg 60.0% vs 25.0% (P=.034).
  • Adverse event rates were comparable between groups with no serious intervention-related events, and the trial was stopped early after dexamethasone showed greater benefit.
PubMed indexed 31 Mar 2026 Imported 9 Nov 2026 McCormick ZL et al. Publisher Chronic painPharmacology
RCT Anesth Analg Published 27 Aug 2026
Influence of Surgical-Level Propofol Anesthesia on Non-Rapid Eye Movement and Rapid Eye Movement Sleep in Aged Mice.
AI-generated abstract summary · verify against the original paper
  • Preclinical study of 20 aged mice (18–20 months) with 24-hour EEG recordings, comparing propofol, an intralipid vehicle, and baseline controls.
  • Propofol was infused to surgical-level anesthesia, titrated to EEG delta waves, with an equal volume of intralipid as the vehicle comparator.
  • Propofol mice had more wakefulness (820 ± 93.3 vs 658 ± 71.1 min; P < .001) and less NREM sleep (539 ± 93.3 vs 699 ± 64.2 min; P < .001) than controls.
  • Early after emergence, REM sleep fell (4.31 ± 2.81 vs 23.1 ± 8.26 min; P < .001), and the authors report delayed REM rebound despite satisfied NREM homeostasis.
PubMed indexed 31 Aug 2026 Imported 9 Nov 2026 Jedrusiak M et al. Publisher Pharmacology
RCT J Clin Anesth Published 22 Aug 2026
Opioid-sparing anesthesia based on opioid-free principles for early recovery after total knee arthroplasty: A randomized controlled trial.
AI-generated abstract summary · verify against the original paper
  • Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
  • Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
  • At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
  • The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
PubMed indexed 22 Aug 2026 Imported 9 Nov 2026 Liu J et al. Publisher PharmacologyRegional
RCT J Cardiothorac Vasc Anesth Published 21 Aug 2026
Renoprotective Effects of Dexmedetomidine Versus Dopamine in High-Risk Renal Patients Undergoing Off-Pump Coronary Artery Bypass Grafting:A Prospective, Randomized, Comparative Study.
AI-generated abstract summary · verify against the original paper
  • Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
  • Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
  • Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
  • No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Maity S et al. Publisher CardiacPerioperative medicinePharmacology